Evidence map›Paper›PMID 15815020›Full record

ArticleJournal of clinical microbiology2005

Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus.

Bram Diederen, Inge van Duijn, Alex van Belkum, Piet Willemse, Peter van Keulen, Jan Kluytmans

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Understanding short-term transmission dynamics of methicillin-resistantInfection control and hospital epidemiology · 2022
    Observational
  7. Article
  8. Article
  9. Article
  10. Occurrence of multidrug-resistant methicillin-resistantInternational journal of veterinary science and medicine · 2019
    Article
  11. Review
  12. Article
  13. Chromogenic media for MRSA diagnostics.Molecular biology reports · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bram DiederenLaboratory of Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands. b.diederen@elisabeth.nl
Inge van Duijn
Alex van Belkum
Piet Willemse
Peter van Keulen
Jan Kluytmans

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CHROMagar MRSA was evaluated for its ability to identify methicillin-resistant Staphylococcus aureus (MRSA). A well-defined collection consisting of 216 MRSA strains and 241 methicillin-susceptible Staphylococcus aureus isolates was used. The sensitivity of CHROMagar MRSA after 24 h of incubation was 95.4%, increasing to 100% after 48 h. The specificity was already 100% after 24 h.

Indexed as

Culture MediaMethicillin ResistanceChromogenic CompoundsHumansSensitivity and SpecificityStaphylococcus aureusChromogenic CompoundsCulture Media

Identifiers

PMID15815020
PMCPMC1081383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.